European Archives - Page 286 of 1216 - European Medical Journal

Tralokinumab in Atopic Dermatitis

To discuss how biologics have disrupted clinical management of atopic dermatitis, and how tralokinumab fits into this paradigm, the EMJ sat…

Lack of Synonymity Between 'Cubital Gust of Wind' and Rheumatoid Arthritis

Jaccoud’s hand is a rare deforming arthropathy, first described in 1869 by Sigismond Jaccoud. Joint deformities are usually reversible…

Advances in Treatment for Hair Loss Conditions

Hair loss is a common problem in clinical dermatology, with many aetiologies including but not limited to androgenetic alopecia…

EADV 2024 Abstract Highlights

AI has shown promise by analysing data from patient records to recognise complex patterns within large datasets, which can aid in the early…

Update on Low-Molecular Weight Hyaluronic Acid

Hyaluronan, or hyaluronic acid (HA), is an extracellular matrix glycosaminoglycan distributed throughout the body, primarily found in…

Autosomal Recessive Congenital Ichthyosis: Report of an Attenuated Phenotype

Congenital ichthyosis represents keratinisation disorders characterised by abnormal skin scaling across the entire body, leading to a red…

Pigmented Variants of Basal Cell Carcinoma

Basal cell carcinoma (BCC) is a heterogeneous malignant neoplasm and can cause great morbidity as most occur in highly visible areas of…

New Study Links Fibrosis to Severe MASLD Outcomes

A new study examined the influence of clinical and histologic risk factors on long-term MASLD outcomes in patients confirmed via liver biopsy.

white house on blue background

What does Trump's win mean for pharma?

With Donald Trump securing a second presidential term, what issues should be top of mind for the pharmaceutical sector in the US?

Higher Risk of Mortality in Young Patients Undergoing TAVR

Patients under 65 years undergoing TAVR exhibit a higher comorbidity burden and greater all-cause mortality